Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. A. deGraffenried
Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer
Oncogenesis
Cancer Research
Molecular Biology
TAZ Inhibition Restores Sensitivity of Cisplatin via AKT/mTOR Signaling in Lung Adenocarcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Serum Adenosine Deaminase Activity in Iraqi Patients With Breast Cancer on Tamoxifen Therapy
Gaziantep Medical Journal
Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen Through Activation of Akt/mTOR Signaling
PLoS ONE
Multidisciplinary
Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells
Molecular Carcinogenesis
Cancer Research
Molecular Biology
Calmodulin Modulates Akt Activity in Human Breast Cancer Cell Lines
Breast Cancer Research and Treatment
Cancer Research
Oncology
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Rottlerin Exerts Its Anti-Tumor Activity Through Inhibition of Skp2 in Breast Cancer Cells
Oncotarget
Oncology
